PL2066638T3 - Sposób oczyszczania Montelukastu - Google Patents

Sposób oczyszczania Montelukastu

Info

Publication number
PL2066638T3
PL2066638T3 PL07788278T PL07788278T PL2066638T3 PL 2066638 T3 PL2066638 T3 PL 2066638T3 PL 07788278 T PL07788278 T PL 07788278T PL 07788278 T PL07788278 T PL 07788278T PL 2066638 T3 PL2066638 T3 PL 2066638T3
Authority
PL
Poland
Prior art keywords
montelukast
comprised
organic solvent
purification
impurities
Prior art date
Application number
PL07788278T
Other languages
English (en)
Inventor
Guillen Yolanda Gasanz
Llagostera Montserrat Monsalvatje
Escasany Pedro Talavera
Original Assignee
Esteve Quim S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quim S A filed Critical Esteve Quim S A
Publication of PL2066638T3 publication Critical patent/PL2066638T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL07788278T 2006-08-09 2007-08-07 Sposób oczyszczania Montelukastu PL2066638T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83687306P 2006-08-09 2006-08-09
EP06118689A EP1886997A1 (en) 2006-08-09 2006-08-09 Process for the purification of montelukast
PCT/EP2007/058176 WO2008017667A1 (en) 2006-08-09 2007-08-07 Process for the purification of montelukast
EP07788278A EP2066638B8 (en) 2006-08-09 2007-08-07 Process for the purification of montelukast

Publications (1)

Publication Number Publication Date
PL2066638T3 true PL2066638T3 (pl) 2011-07-29

Family

ID=37667497

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07788278T PL2066638T3 (pl) 2006-08-09 2007-08-07 Sposób oczyszczania Montelukastu

Country Status (19)

Country Link
US (1) US20100029945A1 (pl)
EP (2) EP1886997A1 (pl)
JP (1) JP2010500324A (pl)
KR (1) KR20090037445A (pl)
CN (1) CN101490005B (pl)
AT (1) ATE499345T1 (pl)
AU (1) AU2007283613A1 (pl)
CA (1) CA2657017A1 (pl)
DE (1) DE602007012728D1 (pl)
ES (1) ES2361239T3 (pl)
HR (1) HRP20110322T1 (pl)
IL (1) IL195622A (pl)
MX (1) MX2008015135A (pl)
NO (1) NO20090748L (pl)
PL (1) PL2066638T3 (pl)
PT (1) PT2066638E (pl)
RU (1) RU2009108271A (pl)
SI (1) SI2066638T1 (pl)
WO (1) WO2008017667A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7821421B2 (en) 2003-07-07 2010-10-26 Sensomatix Ltd. Traffic information system
US7812168B2 (en) 2005-07-05 2010-10-12 Teva Pharmaceutical Industries Ltd. Purification of montelukast
EP2552892A1 (en) 2010-03-31 2013-02-06 KRKA, D.D., Novo Mesto Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein
JP5553096B2 (ja) * 2012-08-29 2014-07-16 大日本印刷株式会社 高純度モンテルカストの製造法
CN103570619B (zh) * 2013-11-08 2015-12-09 南京靖龙药物研发有限公司 一种孟鲁司特钠衍生物的制备方法
CN105646344B (zh) * 2016-02-29 2018-08-14 山东新时代药业有限公司 一种孟鲁司特的纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107612A1 (en) * 2002-12-30 2005-05-19 Dr. Reddy's Laboratories Limited Process for preparation of montelukast and its salts
EP1708708A1 (en) * 2004-01-30 2006-10-11 Teva Pharmaceutical Industries Ltd. Montelukast free acid polymorphs
EP1711166A1 (en) * 2004-02-03 2006-10-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
US7189853B2 (en) * 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
US20080214822A1 (en) * 2004-11-30 2008-09-04 Medichem, S.A. Process For the Preparation of a Leukotriene Antagonist
WO2006064269A2 (en) * 2004-12-17 2006-06-22 Cipla Limited Salts of leukotriene antagonist montelukast

Also Published As

Publication number Publication date
US20100029945A1 (en) 2010-02-04
IL195622A (en) 2011-03-31
NO20090748L (no) 2009-03-09
EP2066638A1 (en) 2009-06-10
RU2009108271A (ru) 2010-09-20
EP2066638B1 (en) 2011-02-23
CN101490005A (zh) 2009-07-22
HRP20110322T1 (hr) 2011-06-30
EP2066638B8 (en) 2011-10-12
CA2657017A1 (en) 2008-02-14
DE602007012728D1 (de) 2011-04-07
JP2010500324A (ja) 2010-01-07
EP1886997A1 (en) 2008-02-13
CN101490005B (zh) 2011-08-31
AU2007283613A1 (en) 2008-02-14
PT2066638E (pt) 2011-05-16
WO2008017667A1 (en) 2008-02-14
ATE499345T1 (de) 2011-03-15
IL195622A0 (en) 2009-09-01
MX2008015135A (es) 2008-12-15
AU2007283613A8 (en) 2009-01-22
ES2361239T3 (es) 2011-06-15
SI2066638T1 (sl) 2011-06-30
KR20090037445A (ko) 2009-04-15

Similar Documents

Publication Publication Date Title
IL195622A0 (en) Process for the purification of montelukast
AR047498A1 (es) Proceso de extraccion para remocion de impurezas de una corriente de purga oxidante en la sintesis de acido carboxilico
PT2292581E (pt) Processo de extracção para remoção de impurezas de licormãe na síntese de ácido tereftálico
CA2467001A1 (en) Extraction process for removal of impurities from mother liquor in the synthesis of carboxylic acid
CN102910853B (zh) 一种利用h酸废水回收液生产萘系高效减水剂的方法
PL364226A1 (pl) Sposób odzyskiwania i oczyszczania kaprolaktamu zrozpuszczalnika organicznego
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
WO2009137192A3 (en) Purification of sucralose containing feed streams for sucralose crystallization
ATE445574T1 (de) Behandlung von wässrigen flüssigkeiten und herstellung von anthranilsäure
FR2921565B1 (fr) Procede de recuperation d'acides fluorocarboxyliques
WO2008010231A3 (en) A process for the purification of topiramate
WO2008102375A3 (en) A process for preparation of highly pure isotretinoin
BRPI0411925A (pt) processo para separação e recuperação de ácido 3-hidroxipropiÈnico e ácido acrìlico
CA2516811A1 (en) Improved process for isolation and purification of paclitaxel from natural sources
EP1813635A4 (en) PROCESS FOR THE PRODUCTION OF POLYETHERS AND POLYMERS
AR064357A1 (es) Purificacion de bisulfito de una alfa-ceto
WO2002068330A3 (en) Process and apparatus for the production of calcium bromide by liquid-liquid extraction
BR0111412A (pt) Processos para recuperar um ácido orgânico ou um sal de metal do mesmo de uma fase alcoólica
WO2009072360A1 (ja) ClO3Fの除去方法
JP2009007257A (ja) ケルセチン含有植物材料を用いたケルセチンスルホン酸の製造方法
WO2005002523A3 (en) Process for preparing highly pure and free-flowing solid of 7-ethyltryptophol
CN104277052A (zh) 一种左氧氟沙星或氧氟沙星的合成方法
GB2443146A (en) Novel method of exraction of 6-0-protected trichlorogalac tose from the chlorinated mass
BR112014006984A2 (pt) processos e intermediários para a preparação de um inibidor macrocíclico de proteases do hcv
MX2007004191A (es) Metodo para depurar derivados de 3-hidroxi-amidino-fenilalanina mediante la precipitacion y recristalizacion de una sal con un acido sulfonico aromatico.